Termination of Pregnancy Clinical Trial
Official title:
Comparison of Surgical Versus Medical Termination of Pregnancy Between 13-20 Weeks of Gestation in Ethiopia: A Quasi-experimental Study.
The purpose of the study is to determine the safety and effectiveness of dilation and evacuation for surgical abortion as compared to medical abortion
All patients with a gestational age between 13-20 weeks are fully counseled on the risks and benefits and given the option of medical or surgical abortion. Those who choose medical abortion receive mifepristone 200 mg on day 1 and are appointed to return to SPHMMC 24-48 hours later for admission and misoprostol administration. Those who chose surgical abortion are given mifepristone 200 mg with or without laminaria and appointed to return the next day for surgical abortion. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05326854 -
NAVIGATION ASSISTED CARE PROGRAM AND TERMINATION OF PREGNANCY
|
N/A | |
Completed |
NCT00994734 -
Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion
|
N/A | |
Not yet recruiting |
NCT04303949 -
Multi-Media E-Book for Second‐Trimester Termination Due to Fetal Anomaly
|
N/A | |
Completed |
NCT04910958 -
Impact of COVID-19 Pandemic on Early Spontaneous Abortions and Early Termination of Pregnancy
|
||
Completed |
NCT03393455 -
Obstetric & Pediatric Evolution Following Parental Refusal for Early Termination of Pregnancy Despite Fetal Risk
|
||
Completed |
NCT03877900 -
A Feasibility Study of Virtopsy With Tissue Sampling in Besancon University Hospital
|
||
Completed |
NCT02597699 -
Use of Ultiva ® Associated With Xylocaine ® in the Procedures of Feticide
|
Phase 3 | |
Enrolling by invitation |
NCT03494842 -
TENS for Suction Evacuation for Termination of 1st Trimester Pregnancies
|
N/A | |
Completed |
NCT01811056 -
Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion
|
N/A | |
Completed |
NCT03802149 -
Ulipristal Acetate for Cervical Preparation
|
Early Phase 1 |